Publications for Eberhard Varenhorst
Co-author map based on ISI articles 2007-

Publications mentioned in social media 14 times*

Keywords

tumours treatment survival serum register psa prostate pca patients localized incidence hot flashes diagnosis death curative cardiovascular carcinoma cancer androgen

Journal Articles

Mieke Van Hemelrijck, Annette Wigertz, Fredrik Sandin, Hans Garmo, Karin Hellstrom, Per Fransson, Anders Widmark, Mats Lambe, Jan Adolfsson, Eberhard Varenhorst, Jan-Erik Johansson and Par Stattin
  Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0
  International Journal of Epidemiology, 2013, 42(4), 956-967.
 Web of Science® Times Cited: 9

Sam Ladjevardi, Anders Berglund, Eberhard Varenhorst, Ola Bratt, Anders Widmark and Gabriel Sandblom
  Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL
 
Altmetric usage: 1

  BJU International, 2013, 111(3), 381-388.
 Web of Science® Times Cited: 2

Sabina Davidsson, Michelangelo Fiorentino, Ove Andren, Fang Fang, Lorelei A Mucci, Eberhard Varenhorst, Katja Fall and Jennifer R Rider
  Inflammation, Focal Atrophic Lesions, and Prostatic Intraepithelial Neoplasia with Respect to Risk of Lethal Prostate Cancer
  Cancer Epidemiology, Biomarkers and Prevention, 2011, 20(10), 2280-2287.
 Web of Science® Times Cited: 13

Pe rOlov Hedlund, Robert Johansson, Jan Erik Damber, Inger Hagerman, Peter Henriksson, Peter Iversen, Peter Klarskov, Peter Mogensen, Finn Rasmussen and Eberhard Varenhorst
  Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial
  Scandinavian Journal of Urology and Nephrology, 2011, 45(5), 346-353.
 Web of Science® Times Cited: 7

Gabriel Sandblom, Eberhard Varenhorst, Johan Rosell, Owe Lofman and Per Carlsson
  Letter: PROSTATE CANCER SCREENING Authors reply
  BMJ. British Medical Journal, 2011, 342, .

Gabriel Sandblom, Eberhard Varenhorst, Johan Rosell, Owe Lofman and Per Carlsson
  Randomised prostate cancer screening trial: 20 year follow-up
 
Altmetric usage: 11

  BRITISH MEDICAL JOURNAL, 2011, 342(d1539), .
   Fulltext  PDF  
 Web of Science® Times Cited: 45

Andrea Sboner, Francesca Demichelis, Stefano Calza, Yudi Pawitan, Sunita R Setlur, Yujin Hoshida, Sven Perner, Hans-Olov Adami, Katja Fall, Lorelei A Mucci, Philip W Kantoff, Meir Stampfer, Swen-Olof Andersson, Eberhard Varenhorst, Jan-Erik Johansson, Mark B Gerstein, Todd R Golub, Mark A Rubin and Ove Andren
  Molecular sampling of prostate cancer: a dilemma for predicting disease progression
  BMC MEDICAL GENOMICS, 2010, 3(8), .
   Fulltext  PDF  
 Web of Science® Times Cited: 51

Sam Ladjevardi, Gabriel Sandblom, Anders Berglund and Eberhard Varenhorst
  Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer
  EUROPEAN UROLOGY, 2010, 57(4), 631-638.
 Web of Science® Times Cited: 8

Patiyan Andersson, Eberhard Varenhorst and Peter Söderkvist
  Association studies on INS and IRS1polymorphisms: IRS1 G972R is associated with increased prostate cancer risk
  Prostate Cancer and Prostatic Diseases, 2008, , .

G. Sandblom, S. Ladjevardi, H. Garmo and Eberhard Varenhorst
  The impact of prostate-specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate
 
Altmetric usage: 1

  Cancer, 2008, 112(4), 813-819.
 Web of Science® Times Cited: 8

Sunita R. Setlur, Kirsten D. Mertz, yujin Hoshida, Francesca Demichelis, Mathieu Lupien, Sven Perner, Andrea Sboner, Yudi Pawitan, Ove Andrén, Laura A. Johnson, Jeff Tang, Hans-Olov Adami, Stefano Calza, Arul M. Chinnaiyan, Daniel Rhodes, Scott Tomlins, Katja Fall, Lorelei A. Mucci, Philip W. Kantoff, Meir J. Stampfer, Swen-Olof Andersson, Eberhard Varenhorst, Jan-Erik Johansson, Myles Brown, Todd R. Golub and Mark A. Rubin
  Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer
 
Altmetric usage: 1

  Journal of the National Cancer Institute, 2008, 100(11), 815-825.
 Web of Science® Times Cited: 129

G Sandblom and Eberhard Varenhorst
  Letter: Prostate cancer screening
  Cancer Causes and Control, 2008, 19(10), 1411-1411.

P. O. Hedlund, J. E. Damber, I. Hagerman, S Haukaas, P. Henriksson, P. Iversen, R. Johansson, P Klarskov, F. Lundbeck, F. Rasmussen, Eberhard Varenhorst and J. Viitanen
  Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5
  Scandinavian Journal of Urology and Nephrology, 2008, 42(3), 220-229.
 Web of Science® Times Cited: 17

Katja Fall, Fredrik Strömberg, Johan Rosell and Eberhard Varenhorst
  Reliability of death certificates in prostate cancer patients
  Scandinavian Journal of Urology and Nephrology, 2008, 42(4), 352-357.
 Web of Science® Times Cited: 27

David Robinson, Gabriel Sandblom, Robert Johansson, Hans Garmo, Gunnar Aus, Per Olov Hedlund and Eberhard Varenhorst
  PSA Kinetics Provide Improved Prediction of Survival in Metastatic Hormone-Refractory Prostate Cancer
  Urology, 2008, 72(4), 903-907.
 Web of Science® Times Cited: 11

David Robinson, Gabriel Sandblom, Robert Johansson, Hans Garmo, Pär Stattin, Sören Mommsen and Eberhard Varenhors
  Prediction of Survival of Metastatic Prostate Cancer Based on Early Serial Measurements of Prostate Specific Antigen and Alkaline Phosphatase
  Journal of Urology, 2008, 179(1), 117-123.
 Web of Science® Times Cited: 7

Jan Adolfsson, Hans Garmo, Eberhard Varenhorst, Göran Ahlgren, Christer Ahlstrand, Ove Andrén, Ann Bill-Axelson, Ola Bratt, Jan-Erik Damber, Karinq Hellström, Magnus Hellström, Erik Holmberg, Lars Holmberg, Jonas Hugosson, Jan-Erik Johansson, Bill Pettersson, Magnus Törnblom, Anders Widmark and Pär Stattin
  Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005
  Scandinavian Journal of Urology and Nephrology, 2007, 41(6), 456-477.
 Web of Science® Times Cited: 72

David Robinson, Gunnar Aus, Julia Bak, Tomasz Gorecki, Anders Herder, Johan Rosell and Eberhard Varenhorst
  Long-term follow-up of conservatively managed incidental carcinoma of the prostate A multivariate analysis of prognostic factors
  Scandinavian Journal of Urology and Nephrology, 2007, 41(2), 103-109.
 Web of Science® Times Cited: 13

Patiyan Andersson, Eberhard Varenhorst and Peter Söderkvist
  Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk
  European Journal of Cancer, 2006, 42(16), 2833-2837.
 Web of Science® Times Cited: 18

Bill Pettersson, Eberhard Varenhorst, A. Petas and J. Sandow
  Duration of Testosterone Suppression after a 9.45 mg Implant of the GnRH-Analogue Buserelin in Patients with Localised Carcinoma of the Prostate. A 12-Month Follow-up Study
  European Urology, 2006, 50(3), 483-489.
 Web of Science® Times Cited: 7

Karin Sennfält, Per Carlsson and Eberhard Varenhorst
  Diffusion and Economic Consequences of Health Technologies in Prostate Cancer Care in Sweden, 1991-2002
  European Urology, 2006, 49(6), 1028-1034.
 Web of Science® Times Cited: 8

P. Stattin, R. Johansson, R. Lodnert, O. Andren, A. Bill-Axelsson, O. Bratt, J.-E. Damber, M. Hellstrom, J. Hugosson, R. Lundgren, M. Tornblom, Eberhard Varenhorst and J.-E. Johansson
  Geographical variation in incidence of prostate cancer in Sweden: Survey from the National Prostate Cancer Register
  Scandinavian Journal of Urology and Nephrology, 2005, 39(5), 372-379.
 Web of Science® Times Cited: 8

Claes R Nyman, Jesper T Andersen, Per Lodding, Thorsten Sandin and Eberhard Varenhorst
  The patient's choice of androgen-deprivation therapy in locally advanced prostate cancer: Bicalutamide, a gonadotrophin-releasing hormone analogue or orchidectomy
  BJU International, 2005, 96(7), 1014-1018.
 Web of Science® Times Cited: 11

Gunnar Aus, David Robinson, Johan Rosell, Gabriel Sandblom and Eberhard Varenhorst
  Survival in prostate carcinoma - Outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: Results from three counties in the population-based National Prostate Cancer Registry of Sweden
  Cancer, 2005, 103(5), 943- 951.
 Web of Science® Times Cited: 32

Eberhard Varenhorst, Hans Garmo, Lars Holmberg, Jan Adolfsson, Jan-Erik Damber, Magnus Hellström, Jonas Hugosson, Rolf Lundgren, Pär Stattin, Magnus Törnblom and Jan-Erik Johansson
  The national prostate cancer register in Sweden 1998 - 2002: trends in incidence, treatment and survival
  Scandinavian Journal of Urology and Nephrology, 2005, 39, 117-123.
 Web of Science® Times Cited: 38

Karin Sennfält, G. Sandblom, Per Carlsson and Eberhard Varenhorst
  Costs and effects of prostate cancer screening in Sweden: a 15-year follow-up of a randomized trial
  Scandinavian Journal of Urology and Nephrology, 2004, 38(4), 291-298.
 Web of Science® Times Cited: 15

Gabriel Sandblom and Eberhard Varenhorst
  Broadening the criteria for avoiding staging one scans in prostate cancer: A retrospective study of patients at the Royal Marsden Hospital
  BJU International, 2004, 93, 889-890.

Gabriel Sandblom and Eberhard Varenhorst
  How should a screening programme for prostate cancer be designed? A case of aiming at a moving target
  Cancer therapy, 2004, 2, 441-454.

Gabriel Sandblom, Eberhard Varenhorst, Owe Löfman, Johan Rosell and Per Carlsson
  Clinical consequences of screening for prostate cancer: 15 Years follow-up of a randomised controlled trial in Sweden
  European Urology, 2004, 46(6), 717-723.
 Web of Science® Times Cited: 52

G Sandblom, Per Carlsson, Karin Sennfält and Eberhard Varenhorst
  A population-based study of pain and quality of life during the year before death in men with prostate cancer
  British Journal of Cancer, 2004, 90(6), 1163-1168.
 Web of Science® Times Cited: 25

Karin Sennfält, Per Carlsson, Gabriel Sandblom and Eberhard Varenhorst
  The estimated economic value of the welfare loss due to prostate cancer pain in a defined population
  Acta Oncologica, 2004, 43(3), 290-296.
 Web of Science® Times Cited: 5

Karin Sennfält, Per Carlsson, Johan Thorfinn, Jessica Frisk, Martin Henriksson and Eberhard Varenhorst
  Technological changes in the management of prostate cancer result in increased healthcare costs: a retrospective study in a defined Swedish population
  Scandinavian Journal of Urology and Nephrology, 2003, 37(3), 226-231.
 Web of Science® Times Cited: 8

Gunnar Aus, Kerstin Nordenskjöld, David Robinson, Johan Rosell and Eberhard Varenhorst
  Prognostic Factors and Survival in Node-Positive (N1) Prostate Cancer: A Prospective Study Based on Data from a Swedish Population-Based Cohort
  European Urology, 2003, 43(6), 627-631.
 Web of Science® Times Cited: 16

Anna-Clara Spetz, Eva-Lena Zetterlund, Eberhard Varenhorst and Mats Hammar
  Incidence and management of hot flashes in prostate cancer.
  The journal of supportive oncology, 2003, 1(4), .

P Stattin, R Johansson, JE Damber, M Hellström, J Hugosson, R Lund, Eberhard Varenhorst and JE Johansson
  Non-systematic screening for prostate cancer in Sweden
  Scandinavian Journal of Urology and Nephrology, 2003, 37, 461-465.

Gabriel Sandblom, Monika Dufmats, Mats Olsson and Eberhard Varenhorst
  Validity of a population-based cancer register in Sweden - An assessment of data reproducibility in the South-East Region prostate cancer register
  Scandinavian Journal of Urology and Nephrology, 2003, 37(2), 112-119.
 Web of Science® Times Cited: 29

Per Adolfsson, Christer Ahlstrand, Eberhard Varenhorst and Samuel Svensson
  Lysophosphatidic acid stimulates proliferation of cultured smooth muscle cells from human BPH tissue: Sildenafil and papaverin generate inhibition
  The Prostate, 2002, 51(1), 50-58.
 Web of Science® Times Cited: 24

Caroline Larsson, Pether Carlsson and Eberhard Varenhorst
  Test med vallmofrön ger vägledning vid svårdiagnostiserad vesikoenteral fistel
  Läkartidningen, 2002, 99, 3703-3705.

Per Olov Hedlund, Martti Ala-Opas, Einar Brekkan, Jan Erik Damber, Lena Damber, Inger Hagerman, Svein Haukaas, Peter Henriksson, Peter Iversen, Åke Pousette, Finn Rasmussen, Jaakko Salo, Sigmund Vaage and Eberhard Varenhorst
  Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer
  Scandinavian Journal of Urology and Nephrology, 2002, 36, 405-413.

Gabriel Sandblom, L. Holmberg, J-E Damber, J. Hugosson, J-E Johansson, R. Lundgren, E. Mattsson, J. Nilsson and Eberhard Varenhorst
  Prostate-Specific Antigen for Prostate Cancer Staging in a Population-based Register
  Scandinavian Journal of Urology and Nephrology, 2002, 36(2), 99-105.
 Web of Science® Times Cited: 5

Gabriel Sandblom, L. Holmberg, J-E Damber, J. Hugosson, J-E Johansson, R, Lundgren, E. Mattsson, J. Nilsson and Eberhard Varenhorst
  Prostate-specific Antigen as Surrogate for Characterizing Prostate Cancer Subgroups
  Scandinavian Journal of Urology and Nephrology, 2002, 36(2), 106-112.
 Web of Science® Times Cited: 4

Anna-Clara Spetz, Mats Hammar, W Pettersson and Eberhard Varenhorst
  Hot flushes and prostate cancer: pathogenesis and treatment
  BJU International, 2002, 90, 476-476.
 Web of Science® Times Cited: 3

Yvonne Wyon, Anna-Clara Spetz, Mats Hammar, Elvar Theodorsson and Eberhard Varenhorst
  Urinary excretion of calcitonin gene-related peptide in males with hot flushes after castration for carcinoma of the prostate
  Scandinavian Journal of Urology and Nephrology, 2001, 35(2), 92-96.
 Web of Science® Times Cited: 9

Anna-Clara Spetz, Mats Hammar, Bengt Lindberg, Anders Spångberg and Eberhard Varenhorst
  Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate
  Journal of Urology, 2001, 166(2), 517-520.
 Web of Science® Times Cited: 38

Gabriel Sandblom, Per Carlsson, Peter Sigsjö and Eberhard Varenhorst
  Pain and health-related quality of life in a geographically defined population of men with prostate cancer
  British Journal of Cancer, 2001, 85(4), 497-503.
 Web of Science® Times Cited: 24

Gabriel Sandblom and Eberhard Varenhorst
  Incidence rate and management of prostate carcinoma
  Biomedicine and Pharmacotherapy, 2001, 55(3), 135-143.
 Web of Science® Times Cited: 6

Anna-Clara Spetz, Bill Pettersson, Eberhard Varenhorst, Elvar Theodorsson, Lars-Håkan Thorell and Mats Hammar
  Momentary increase in plasma calcitonin gene-related peptide is involved in hot flashes in men treated with castration for carcinoma of the prostate
  Journal of Urology, 2001, 166(5), 1720-1723.
 Web of Science® Times Cited: 24

CJ Tyrrell, JE Altwein, F Klippel, C Jurincic-Winkler, Eberhard Varenhorst, G Lunglmayr, F Boccardo, IM Holdaway, J-M Haefliger and JP Jordaan
  Comparison of an LH-RH analogue (Goeserelin acetate, ´Zoladex´) with combined androgen blockade in advanced prostate cancer: Final survival results of an internaitonal multicentre randomized-trial.
  European Urology, 2000, 37, 205-211.

F Helgesen, S-O Andersson, O Gustavsson, Eberhard Varenhorst, B Gobén, S Carnock, Per Carlsson, L Holmberg and J-E Johansson
  Follow-up prostate cancer patients by on-demand contacts with a specialist nurse.
  Scandinavian Journal of Urology and Nephrology, 2000, 34, 55-61.
 Web of Science® Times Cited: 29

Gabriel Sandblom, Monika Dufmats, Kerstin Nordenskjöld and Eberhard Varenhorst
  Prostate carcinoma trends in three counties in Sweden 1987–1996
  Cancer, 2000, 88(6), 1445-1453.
 Web of Science® Times Cited: 30

Gabriel Sandblom, Monika Dufmats and Eberhard Varenhorst
  Long-term survival in a swedish population-based cohort of men with prostate cancer
  Urology, 2000, 56(3), 442-447.
 Web of Science® Times Cited: 27

C Köhler and Eberhard Varenhorst
  Mikroskopisk hematuri hos vuxna - ett diagnostiskt dilemma.
  Läkartidningen, 1999, 96, 4911-4916.

D Kalman and Eberhard Varenhorst
  The role of arterial embolization in renal cell carcinoma.
  Scandinavian Journal of Urology and Nephrology, 1999, 33, 162-170.

Gabriel Sandblom, Elisabet Mattsson, Jonas Nilsson, Jan-Erik Damberg, Jan-Erik Johansson, Rolf Lundgren and Eberhard Varenhorst
  Prostate Cancer Registration in Four Swedish Regions 1996: Differences in Incidence, Age Structure and Management
  Scandinavian Journal of Urology and Nephrology, 1999, 33(5), 306-311.

Håkan Holmberg, Per Carlsson, Disa Kalman and Eberhard Varenhorst
  Impact on health service cost of medical technologies used in management of prostatic cancer
  Scandinavian Journal of Urology and Nephrology, 1998, 32(3), 195-199.

Håkan Holmberg, Per Carlsson, Owe Löfman and Eberhard Varenhorst
  Economic evaluation of screening for prostate cancer: a randomized populaionbased programme during a 10 year period in Sweden
  Health Policy, 1998, 45(2), 133-147.

Sven-Göran Fransson and Ebenhard Varenhorst
  Tveksamt värde av renal angiografi vid makroskopisk hematuri utan urografifynd
  Läkartidningen, 1984, (81), 1720-1721.

Chapters in Books

Gabriel Sandblom and Eberhard Varenhorst
  Clinical and economic consequences of screening for prostate cancer - the Swedish approach
  Recent Research Developments in Cancer - årsbok, Transworld Research Network, 2005, 19-35.


Eberhard Varenhorst and Sven-Göran Fransson
  Nierenarteriographie bei Makrohämaturie unklarer Genese: Analyse von 44 Fällen
  20. bis 23. Oktober 1982, Hamburg, Springer Berlin/Heidelberg, 1983, 325-326.


Conference Articles

S. Davidsson, M. Fiorentino, O. Andren, F. Fang, L. A. Mucci, Eberhard Varenhorst, K. Fall and J.R. Stark
  Focal Prostate Atrophic Lesions and Risk of Lethal Prostate Cancer in LABORATORY INVESTIGATION, vol 91, issue , pp 187A-187A
  LABORATORY INVESTIGATION, 2011.


Anna-Clara Spetz, Mats Hammar and Eberhard Varenhorst
  Hot flushes in men - Prevalence and possible mechnisms
  Menopause, 2003.


 Web of Science® Times Cited: 1

Ph.D. Theses

David Robinson
  Prediction of survival in prostate cancer: aspects on localised, locally advanced and metastatic disease
  2008.


  Fulltext PDF

Hans Hjertberg
  The use of ethanol as a marker to detect and quantify the absorption of irrigation fluid during transurethral resection of the prostate
  1996.


* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.